EA
AGIO icon

Emerald Acquisition’s Agios Pharmaceuticals AGIO Stock Holding History

Emerald Acquisition’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$640K Buy
12,112
+4,501
+59% +$196K ﹤0.01% 2344
2016
Q2 		$319K Buy
+7,611
New +$376K ﹤0.01% 2622

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Emerald Acquisition's AGIO Position: Q3 2016 in Review

Emerald Acquisition increased its Agios Pharmaceuticals (AGIO) stake by 59% in Q3 2016, buying an estimated $196K and bringing the position to 12,112 shares worth $640K. The position accounts for ﹤0.01% of the portfolio, ranked #2344.

Emerald Acquisition first reported a position in AGIO in Q2 2016 and has held it in 2 quarters since. 163 funds tracked by Wall St. Rank hold AGIO as of Q3 2016.

  • Emerald Acquisition held 12,112 shares of Agios Pharmaceuticals worth $640K as of Q3 2016.
  • Emerald Acquisition bought 4,501 Agios Pharmaceuticals shares in Q3 2016, an estimated $196K.
  • Agios Pharmaceuticals made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2344 holding.
  • Emerald Acquisition first reported a position in Agios Pharmaceuticals in Q2 2016 and has held it in 2 quarters since.
  • 163 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.